Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1964 1
1965 1
1967 2
1968 1
1969 1
1971 1
1982 1
1986 1
1988 2
1989 4
1991 2
1993 1
1995 1
1996 2
1997 1
2000 1
2001 1
2003 2
2004 1
2006 2
2008 1
2009 2
2010 1
2011 2
2012 2
2013 1
2014 2
2015 5
2016 6
2017 5
2018 7
2019 6
2020 3
2021 8
2022 8
2023 3
2024 4
2025 0

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

90 results

Results by year

Filters applied: . Clear all
Page 1
Identification of MRTX1133, a Noncovalent, Potent, and Selective KRASG12D Inhibitor.
Wang X, Allen S, Blake JF, Bowcut V, Briere DM, Calinisan A, Dahlke JR, Fell JB, Fischer JP, Gunn RJ, Hallin J, Laguer J, Lawson JD, Medwid J, Newhouse B, Nguyen P, O'Leary JM, Olson P, Pajk S, Rahbaek L, Rodriguez M, Smith CR, Tang TP, Thomas NC, Vanderpool D, Vigers GP, Christensen JG, Marx MA. Wang X, et al. Among authors: vanderpool d. J Med Chem. 2022 Feb 24;65(4):3123-3133. doi: 10.1021/acs.jmedchem.1c01688. Epub 2021 Dec 10. J Med Chem. 2022. PMID: 34889605 Free article.
MRTX1719 Is an MTA-Cooperative PRMT5 Inhibitor That Exhibits Synthetic Lethality in Preclinical Models and Patients with MTAP-Deleted Cancer.
Engstrom LD, Aranda R, Waters L, Moya K, Bowcut V, Vegar L, Trinh D, Hebbert A, Smith CR, Kulyk S, Lawson JD, He L, Hover LD, Fernandez-Banet J, Hallin J, Vanderpool D, Briere DM, Blaj A, Marx MA, Rodon J, Offin M, Arbour KC, Johnson ML, Kwiatkowski DJ, Jänne PA, Haddox CL, Papadopoulos KP, Henry JT, Leventakos K, Christensen JG, Shazer R, Olson P. Engstrom LD, et al. Among authors: vanderpool d. Cancer Discov. 2023 Nov 1;13(11):2412-2431. doi: 10.1158/2159-8290.CD-23-0669. Cancer Discov. 2023. PMID: 37552839 Free PMC article. Clinical Trial.
Anti-tumor efficacy of a potent and selective non-covalent KRASG12D inhibitor.
Hallin J, Bowcut V, Calinisan A, Briere DM, Hargis L, Engstrom LD, Laguer J, Medwid J, Vanderpool D, Lifset E, Trinh D, Hoffman N, Wang X, David Lawson J, Gunn RJ, Smith CR, Thomas NC, Martinson M, Bergstrom A, Sullivan F, Bouhana K, Winski S, He L, Fernandez-Banet J, Pavlicek A, Haling JR, Rahbaek L, Marx MA, Olson P, Christensen JG. Hallin J, et al. Among authors: vanderpool d. Nat Med. 2022 Oct;28(10):2171-2182. doi: 10.1038/s41591-022-02007-7. Epub 2022 Oct 10. Nat Med. 2022. PMID: 36216931
Biliary lithotripsy.
Vanderpool D, Jones RC, O'Leary JP, Hamilton JK. Vanderpool D, et al. Am J Surg. 1989 Sep;158(3):194-7. doi: 10.1016/0002-9610(89)90251-1. Am J Surg. 1989. PMID: 2672841 Review.
The Standard of Care.
Vanderpool D. Vanderpool D. Innov Clin Neurosci. 2021 Jul-Sep;18(7-9):50-51. Innov Clin Neurosci. 2021. PMID: 34980995 Free PMC article.
Cholecystectomy.
Vanderpool D, Lane BW, Winter JW 4th, Bone GE. Vanderpool D, et al. South Med J. 1989 Apr;82(4):450-2. doi: 10.1097/00007611-198904000-00011. South Med J. 1989. PMID: 2705071
Bark Beetle Population Dynamics in the Anthropocene: Challenges and Solutions.
Biedermann PHW, Müller J, Grégoire JC, Gruppe A, Hagge J, Hammerbacher A, Hofstetter RW, Kandasamy D, Kolarik M, Kostovcik M, Krokene P, Sallé A, Six DL, Turrini T, Vanderpool D, Wingfield MJ, Bässler C. Biedermann PHW, et al. Among authors: vanderpool d. Trends Ecol Evol. 2019 Oct;34(10):914-924. doi: 10.1016/j.tree.2019.06.002. Epub 2019 Jun 28. Trends Ecol Evol. 2019. PMID: 31262532 Free article. Review.
HIPAA COMPLIANCE: A Common Sense Approach.
Vanderpool D. Vanderpool D. Innov Clin Neurosci. 2019 Jan 1;16(1-2):38-41. Innov Clin Neurosci. 2019. PMID: 31037229 Free PMC article.
Risk Management: Fact or Ficton.
Vanderpool D. Vanderpool D. Innov Clin Neurosci. 2021 Oct-Dec;18(10-12):38-39. Innov Clin Neurosci. 2021. PMID: 35096482 Free PMC article.
The SOS1 Inhibitor MRTX0902 Blocks KRAS Activation and Demonstrates Antitumor Activity in Cancers Dependent on KRAS Nucleotide Loading.
Sudhakar N, Yan L, Qiryaqos F, Engstrom LD, Laguer J, Calinisan A, Hebbert A, Waters L, Moya K, Bowcut V, Vegar L, Ketcham JM, Ivetac A, Smith CR, Lawson JD, Rahbaek L, Clarine J, Nguyen N, Saechao B, Parker C, Elliott AJ, Vanderpool D, He L, Hover LD, Fernandez-Banet J, Coma S, Pachter JA, Hallin J, Marx MA, Briere DM, Christensen JG, Olson P, Haling J, Khare S. Sudhakar N, et al. Among authors: vanderpool d. Mol Cancer Ther. 2024 Oct 1;23(10):1418-1430. doi: 10.1158/1535-7163.MCT-23-0870. Mol Cancer Ther. 2024. PMID: 38904222 Free PMC article.
90 results